Large segment DNA synthesis technology is one of the key and difficult points in the development of technology in the field of gene synthesis at present. The commercial synthesis and delivery of large segment DNA has become the core foundation of synthetic Genomics in the future, forming a key driving force in the development and application of Synthetic biology.
DIA-UP BIOTECH Difficulty Gene Synthesis Service
Innovation Exploration · Technology Pioneer
Accurate synthesis and stable delivery
As an intelligent service platform for gene synthesis and precise sequencing, Deauping has always adhered to independent innovation and research and development for more than a decade, has industry-leading Synthetic biology technology, and has constantly expanded resource input and improved the service capacity of the platform. Not only can it easily handle the synthesis of large fragments of DNA with complex structures, but it can also provide synthesis services involving difficult genes such as high GC, low GC, repetitive sequences, toxic DNA, etc. Innovative exploration, technology pioneer, precise synthesis, stable delivery, continue to give new help and strength to Synthetic biology researchers!
Synthesis of Large Fragment Gene of DIA-UP BIOTECH
DIA-UP BIOTECH has independently developed and optimized gene synthesis methods, which can greatly reduce the degradation rate of primers and the mutation frequency of DNA synthesis. At the same time, it effectively avoids problems such as mismatches and low efficiency of connection transformation during large segment DNA recombination. It can efficiently quantify the synthesis of 8kb long genes, providing you with accurate and timely large segment gene synthesis services.
High difficulty gene synthesis of Deopin
The core technical team of DIA-UP BIOTECH continuously optimizes the sequence design and synthesis technology of difficult genes, and through extensive experimental verification, improves the recombination stability and cloning positive rate of difficult genes. It can help customers accurately complete toxic genes and gene synthesis services with GC-content of 20% -75%.
Why did you choose DIA-UP BIOTECH gene synthesis service?
·The extremely high success rate of template construction is>95%.
·The extremely high recombination positive rate is>95%.
·Mastering the key points of large fragment core technology can quantitatively and accurately synthesize 8kb large fragment DNA.
·Easily cope with difficult gene synthesis, such as high and low GC, repetitive structures, toxic genes, etc.
·Each gene must undergo sequencing verification to ensure 100% accuracy of the sequence.
·Implement a 100000 level clean room and strictly follow the ISO13485:2016 quality management system.
Service Type
DIA-UP BIOTECH
Service Process
DIA-UP BIOTECH
For inquiries about IVD raw materials and research services related products, please contact us through the following methods——
Tel : 185 1363 7192 / 186 1089 6066
E-mile : order@dia-up.com
Add :
Building 18, Yard 2, Huanke Middle Road, Tongzhou District, Beijing
DIA-UP BIOTECH was established in 2012, with a professional technical research and development team with over 10 years of experience, and has won multiple invention patents. The company has built a research and development platform for in vitro diagnostic materials (covering 10 major product systems, including primer and probe synthesis, nucleic acid molecular detection materials, immune reagent materials, biochemical reagent materials, hemagglutination reagent materials, fluorescent immunochromatography POCT large plate, biochemical reagent large package, hemagglutination reagent large package, calibration quality control products, etc.), automated high-throughput DNA reading and writing platform, RNA Intelligent design and synthesis platform, protein antibody preparation platform Five core technology platforms, including the supply platform for scientific research reagents and consumables.
DIA-UP BIOTECH adopts a 100000/10000 level purification workshop for product production and packaging, strictly adhering to the ISO13485:2016 quality management system standards, adhering to the development concept of 'craftsmanship quality, customer achievement', and committed to providing high-quality products and services to customers in the field of in vitro diagnosis and research.